Glass Lewis Recommends Standard BioTools Stockholders Vote “FOR” All Proposals Relating to Proposed Merger with SomaLogic
SOUTH SAN FRANCISCO, Calif., Dec. 29, 2023 (GLOBE NEWSWIRE) — Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health, today announced that a second leading independent proxy advisory firm, Glass, Lewis & Co. (“Glass Lewis”), has recommended that all Standard BioTools stockholders vote “FOR” all proposals relating to the pending merger with SomaLogic at the Company’s upcoming Special Meeting of Stockholders to be held on January 4, 2024.
Related news for (LAB)
- Today’s Top Performers: MoBot’s Market Review 08/22/25 09:00 AM
- Don’t Miss Out: MoBot’s Latest Stock Updates 08/22/25 08:00 AM
- Today’s Top Performers: MoBot’s Market Review 06/23/25 09:00 AM
- Standard BioTools Enters Next Phase of Transformation with Strategic Sale of SomaLogic to Illumina
- 24/7 Market News Snapshot 23 June, 2025 – Standard BioTools Inc. Common Stock (NASDAQ:LAB)